[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352957-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352957-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","transcriptome-and-experimental-validation-identify-prognostic-genes-associated-with-lipotoxicity-in-thyroid-carcinoma","Transcriptome and experimental validation identify prognostic genes associated with lipotoxicity in thyroid carcinoma","","Thyroid carcinoma pathogenesis involves uncertain roles for lipotoxicity-related genes. This study integrates transcriptomic and clinical data from The Cancer Genome Atlas to identify lipotoxicity-related prognostic genes in thyroid carcinoma and to build a Cox regression and machine-learning prognostic model. Model performance is evaluated with immune microenvironment features and drug sensitivity predictions. Prognostic gene expression is experimentally validated in clinical samples using RT-qPCR. Results indicate IL11 and SNAI1 as key prognostic markers and show distinct immune and drug response patterns.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/transcriptome-and-experimental-validation-identify-prognostic-genes-associated-with-lipotoxicity-in-thyroid-carcinoma/352957/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/transcriptome-and-experimental-validation-identify-prognostic-genes-associated-with-lipotoxicity-in-thyroid-carcinoma/352957.png","ImageObject",300,407,{"name":42,"@type":43},"Cipher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which lipotoxicity-related genes were identified as prognostic markers in thyroid carcinoma?","Question",{"text":63,"@type":64},"IL11 and SNAI1 were identified as prognostic markers, with high-risk patients showing elevated mortality.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the prognostic model constructed and evaluated?",{"text":68,"@type":64},"A prognostic model was developed using Cox regression and machine-learning methods, with performance assessment based on the immune microenvironment and drug sensitivity.",{"name":70,"@type":61,"acceptedAnswer":71},"How were the prognostic gene findings validated experimentally?",{"text":72,"@type":64},"Prognostic gene expression was validated by RT-qPCR in clinical samples, showing higher IL11 and lower SNAI1 in thyroid carcinoma tissues compared with normal controls.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352957,1790309623,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Lin etal. BMC Cancer (2026) 26:654  \n[https://doi.org/10.1186/s12885-026-15975-7](https://doi.org/10.1186/s12885-026-15975-7)  \nBMC Cancer  \nRESEARCH Open Access  \nTranscriptome and experimental validation identify prognostic genes associated with lipotoxicity in thyroid carcinoma  \nBin Lin1, Xianqiang Yu1, Min Li1, Weizheng Mao1 and Xiaodong Ding1*  \nAbstract  \nBackground Thyroid carcinoma (THCA) is a malignant tumor. The role of lipotoxicity-related genes (L-RGs) in THCApathogenesis remains unclear.  \nMethods This study integrated transcriptomic and clinical data from The Cancer Genome Atlas to identify and validate lipotoxicity-related prognostic genes in THCA. A prognostic model was developed using Cox regression and machine learning techniques, with performance assessment based on the immune microenvironment and drug sensitivity. Prognostic gene expression was further validated through Reverse Transcription Quantitative PCR (RT-qPCR) in clinical samples.  \nResults IL11 and SNAI1 were identified as prognostic markers. Patients in the high-risk group exhibited elevated mortality. The constructed nomogram demonstrated strong predictive accuracy. Differential immune cell analysis revealed 26 immune cell types, including plasmacytoid dendritic cells (pDCs) . The high-risk group showed heightened sensitivity to cisplatin and gefitinib, suggesting potential drug resistance. RT-qPCR confirmed significantly higher IL11 expression and lower SNAI1 expression in THCA tissues compared to normal controls.  \nConclusion IL11 and SNAI1, identified as lipotoxicity-related prognostic genes, provide valuable insights into THCApathophysiology and offer potential therapeutic targets.  \nKeywords Thyroid carcinoma, Lipotoxicity-related genes, Prognostic genes, Immune microenvironment, Drug sensitivity  \nBackground  \nThyroid carcinoma (THCA) is a malignancy originating from the follicular or parafollicular cells of the thyroid gland and is among the most common endocrine tumors [1]. Recent trends show an increasing incidence of THCA [2]. In 2022, global cancer statistics reported  \n*Correspondence: Xiaodong Ding [dxdrexue@163.com](dxdrexue@163.com)  \n1Department of Thyroid Diseases, Qingdao Hospital (Qingdao Municipal Hospital), University of Health and Rehabilitation Sciences, Qingdao, China  \napproximately 821,173 new THCA cases, reflecting a 4.1% increase, making it the seventh most common cancer worldwide [3]. In China, THCA is the second most prevalent cancer, with an age-standardized incidence rate of 24.6 cases per 100,000 individuals, accounting for over half of the global new cases in 2022 [4]. Despite the rise in incidence, the prognosis for patients diagnosed with differentiated THCA remains generally favorable, particularly when diagnosed and treated early [5]. The most common clinical presentation is a painless neck mass, with additional symptoms such as dysphagia and hoarseness [6]. Treatment options include surgical resection,  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creat","cbCaiogeuAi8RjHs","https://ap.wps.com/l/cbCaiogeuAi8RjHs","pdf",14438377,21,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Background\n## Clinical context of thyroid carcinoma\n## Lipotoxicity and mechanistic basis","[{\"question\":\"Which lipotoxicity-related genes were identified as prognostic markers in thyroid carcinoma?\",\"answer\":\"IL11 and SNAI1 were identified as prognostic markers, with high-risk patients showing elevated mortality.\"},{\"question\":\"How was the prognostic model constructed and evaluated?\",\"answer\":\"A prognostic model was developed using Cox regression and machine-learning methods, with performance assessment based on the immune microenvironment and drug sensitivity.\"},{\"question\":\"How were the prognostic gene findings validated experimentally?\",\"answer\":\"Prognostic gene expression was validated by RT-qPCR in clinical samples, showing higher IL11 and lower SNAI1 in thyroid carcinoma tissues compared with normal controls.\"}]","Transcriptome and experimental validation identify prognostic genes associated with lipotoxicity in thyroid carcinoma | PDF",1790102315,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8015ac79126127b793741988186cb212.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/892d5e48d5124485263a850babd8fd0f.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e66aa0024754b614d7039016379081a4.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab5b2188dd1027b32e844010a00e9295.webp",980,1306]